NCT01089101 2026-03-18Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade GliomaNational Cancer Institute (NCI)Phase 1/2 Active not recruiting220 enrolled
NCT02700230 2024-09-27Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by SurgeryMayo ClinicPhase 1 Completed9 enrolled